Goldman Sachs analyst Corinne Jenkins raised the price target on Geron Corporation (NASDAQ: GERN) to $5.00 (from $4.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst PT Change

After-hours movers: Adobe Systems slumps; Rivian, Ulta Beauty gainMarch 14, 2024 4:48 PM Form 8-K GERON CORP For: Mar 14March 14, 2024 4:10 PM Geron Corp (GERN) Announces FDA Oncologic Drugs Advisory Committee Votes in Favor of the Clinical Benefit/Risk Profile of ImetelstatMarch 14, 2024 3:54 PM Geron Announces FDA Oncologic Drugs Advisory Committee Votes in Favor of the Clinical Benefit/Risk Profile of Imetelstat for the Treatment of Transfusion-Dependent Anemia in Patients with Lower-Risk MMarch 14, 2024 3:54 PM Geron Corp (GERN) Halted, News PendingMarch 14, 2024 6:55 AM Geron Corp (GERN) option IV into FDA Oncologic Drugs Advisory Committee meetingMarch 14, 2024 5:10 AM Increasing unusual option volume: GERN REI CMI ATMU SOUN ALGM TMC RXTMarch 13, 2024 5:35 AM